J. Fahy, H. Fleming, H. Wong, J. Liu, and J. Su, The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects., American Journal of Respiratory and Critical Care Medicine, vol.155, issue.6, pp.1828-1834, 1997.
DOI : 10.1164/ajrccm.155.6.9196082

D. Scott and G. Kingsley, Tumor Necrosis Factor Inhibitors for Rheumatoid Arthritis, New England Journal of Medicine, vol.355, issue.7, pp.704-712, 2006.
DOI : 10.1056/NEJMct055183

M. Riccaboni, I. Bianchi, and P. Petrillo, Spleen tyrosine kinases: biology, therapeutic targets and drugs, Drug Discovery Today, vol.15, issue.13-14, pp.517-530, 2010.
DOI : 10.1016/j.drudis.2010.05.001

W. Wong and K. Leong, Tyrosine kinase inhibitors: a new approach for asthma, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1697, issue.1-2, pp.53-69, 2004.
DOI : 10.1016/j.bbapap.2003.11.013

E. Masuda and J. Schmitz, Syk inhibitors as treatment for allergic rhinitis, Pulmonary Pharmacology & Therapeutics, vol.21, issue.3, pp.461-467, 2008.
DOI : 10.1016/j.pupt.2007.06.002

S. Braselmann, V. Taylor, H. Zhao, S. Wang, and C. Sylvain, R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation, Journal of Pharmacology and Experimental Therapeutics, vol.319, issue.3, pp.998-1008, 2006.
DOI : 10.1124/jpet.106.109058

S. Yanagi, R. Inatome, T. Takano, and H. Yamamura, Syk Expression and Novel Function in a Wide Variety of Tissues, Biochemical and Biophysical Research Communications, vol.288, issue.3, pp.495-498, 2001.
DOI : 10.1006/bbrc.2001.5788

M. Lobato and T. Rabbitts, Intracellular antibodies and challenges facing their use as therapeutic agents, Trends in Molecular Medicine, vol.9, issue.9, pp.390-396, 2003.
DOI : 10.1016/S1471-4914(03)00163-1

S. Dauvillier, P. Merida, M. Visintin, A. Cattaneo, and C. Bonnerot, Intracellular Single-Chain Variable Fragments Directed to the Src Homology 2 Domains of Syk Partially Inhibit Fc??RI Signaling in the RBL-2H3 Cell Line, The Journal of Immunology, vol.169, issue.5, pp.2274-2283, 2002.
DOI : 10.4049/jimmunol.169.5.2274

E. Mazuc, B. Villoutreix, O. Malbec, T. Roumier, and S. Fleury, A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally, Journal of Allergy and Clinical Immunology, vol.122, issue.1, pp.188-194, 2008.
DOI : 10.1016/j.jaci.2008.04.026
URL : https://hal.archives-ouvertes.fr/inserm-00292498

E. Arias-palomo, M. Recuero-checa, X. Bustelo, and O. Llorca, 3D structure of Syk kinase determined by single-particle electron microscopy, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1774, issue.12, pp.1493-1499, 2007.
DOI : 10.1016/j.bbapap.2007.10.008

O. Sperandio, C. Reynes, A. Camproux, and B. Villoutreix, Rationalizing the chemical space of protein???protein interaction inhibitors, Drug Discovery Today, vol.15, issue.5-6, pp.220-229, 2010.
DOI : 10.1016/j.drudis.2009.11.007

J. Wells and C. Mcclendon, Reaching for high-hanging fruit in drug discovery at protein???protein interfaces, Nature, vol.12, issue.7172, pp.1001-1009, 2007.
DOI : 10.1038/nature06526

M. Arkin and A. Whitty, The road less traveled: modulating signal transduction enzymes by inhibiting their protein???protein interactions, Current Opinion in Chemical Biology, vol.13, issue.3, pp.284-290, 2009.
DOI : 10.1016/j.cbpa.2009.05.125

B. Villoutreix, K. Bastard, O. Sperandio, R. Fahraeus, and J. Poyet, In Silico-In Vitro Screening of Protein-Protein Interactions: Towards the Next Generation of Therapeutics, Current Pharmaceutical Biotechnology, vol.9, issue.2, pp.103-122, 2008.
DOI : 10.2174/138920108783955218
URL : https://hal.archives-ouvertes.fr/inserm-00273685

J. An, M. Totrov, and R. Abagyan, Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes, Molecular & Cellular Proteomics, vol.4, issue.6, pp.752-761, 2005.
DOI : 10.1074/mcp.M400159-MCP200

S. Perot, O. Sperandio, M. Miteva, A. Camproux, and B. Villoutreix, Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery, Drug Discovery Today, vol.15, issue.15-16, pp.656-667, 2010.
DOI : 10.1016/j.drudis.2010.05.015

M. Miteva, W. Lee, M. Montes, and B. Villoutreix, Fast Structure-Based Virtual Ligand Screening Combining FRED, DOCK, and Surflex, Journal of Medicinal Chemistry, vol.48, issue.19, pp.6012-6022, 2005.
DOI : 10.1021/jm050262h